BOSUTINIB
UNII 5018V4AEZ0

Substance Identification & Data

This profile provides standardized clinical and technical data for Bosutinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5018V4AEZ0.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 380843-75-4 and the RxNorm Concept ID (RxCUI) 1307619. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5018V4AEZ0

CAS Registry Number

380843-75-4

RxNorm Concept ID

1307619

Detailed Substance Profile

Preferred Name

BOSUTINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

5018V4AEZ0

The specific atomic composition represented as a molecular structure string.

InChIKey

C26H29Cl2N5O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UBPYILGKFZZVDX-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C60809

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

5328940

Unique identification number in the NCBI database of chemical substances.

INN ID

8715

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

RR-46

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(cc2c(cc1OCCCN3CCN(CC3)C)ncc(c2Nc4cc(c(cc4Cl)Cl)OC)C#N)OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bosutinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.